AMY THOMPSON: Open Payments
NPI 1306288485 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,291 in 105 payments from 24 companies in 2025. Trend: 2023 $2,328 · 2024 $2,392 · 2025 $2,291
Food & beverage: $2,279Consulting: $12
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $589 |
| CSL Behring | 11 | $261 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $210 |
| PFIZER INC. | 8 | $184 |
| GlaxoSmithKline, LLC. | 9 | $148 |
| Regeneron Healthcare Solutions, Inc. | 7 | $130 |
| GENZYME CORPORATION | 5 | $119 |
| BioCryst US Sales Co., LLC | 5 | $95 |
| Azurity Pharmaceuticals, Inc. | 3 | $71 |
| Ionis Pharmaceuticals, Inc. | 3 | $64 |
Products named: AIRSUPRA, DUPIXENT, FASENRA, Hizentra, TAKHZYRO, Andembry, ORLADEYO, PANZYGA.
Industry payments across NC — which companies pay providers there.
